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Summary
The mechanism of cell complex formation between lymphocytes and stromal cells was investigated.
We found that lymphoid lines of both T and B lineages could form cell complexes with stromal
cells from the thymus as well as bone marrow but not with macrophages or typical fibroblast
lines. Formation of these cell complexes is temperature dependent and requires the presence of
Mgt+, active cellular metabolism, and microfilament assembly of cytoskeleton. We raised an
antiserum against a thymic stromal cell clone (BATE-2) in rats and found that, after absorption,
this serum could effectively block cell complex formation between lymphocytes and stromal cells
from both thymus and bone marrow. An efficient blocking was obtained only when the antiserum
was added at the initial stage of cell interaction. From the blocking experiments and the SDS-
PAGE analysis of immunoprecipitated materials from the stromal cell surface, we identified a
unique 107-kD glycoprotein on the stromal cells as a molecule for mediating stromal cell-lymphocyte
interaction. This is further supported by the findings that an antiserum raised in hamsters against
the excised gel band corresponding to 107 kD, which specifically immunoprecipitated the 107-kD
molecule, effectively blocked the lymphocyte-stromal cell interaction. The possible function of
this molecule in hematolymphoid development is discussed.
T
he growth and differentiationofmyeloerythroid and lym-
phoid cells from stem cells is strictly regulated by the
microenvironmental elements of their generative organs. Long-
term bone marrow cultures (LTBMC)t, first described by
Dexter et al. (1), result in the establishment of the major
elements of hematopoiesis: the bone marrow stromal microen-
vironments and the hematopoietic cells that respond to them.
Whitlock and Witte (2) developed a modified LTBMC that
supports the differentiationoflymphoid progenitors into pre-B
and B cells. The microenvironmental stroma of both types
of LTBMC appears to be made up of fibroblastoid and en-
dothelial cells (1-6). Recently, functional stromal cell lines
have also been established from the thymus, and these stromal
cells can support at least a part ofthe developmental pathway
of immature thymocytes (7). Further, stromal cell clones es-
t Abbreviations used in this paper: CAM, cellular adhesion molecule; ECM,
extrecellular matrix; GM-CSF, granulocyte/macrophage colony-stimulating
factor; LTBMC, long-term bone marrow culture.
tablished from the spleen have been shown to support the
differentiation oferythroid precursors to mature erythrocytes
in the presence of erythropoietin (8). Taken together, these
results suggest that a given pathway of hematopoietic differen-
tiation must be regulated by distinctive types ofstromal cells.
The regulation of hematopoiesis might be controlled by
cell-to-cell and/or cell-to-extracellular matrix (ECM) adhe-
sion (3-6, 9, 10), and by the elaboration ofvarious cytokines
(11). When hematolymphoid precursor cells are cocultured
with stromal cells, some of the cells attach and actively crawl
underneath the stromal cell surface, resulting in the forma-
tion of multicellular complexes between precursors and stromal
cells. This phenomenon has been described in the thymic
stromal cell-lymphocyte interactions and termed as pseudo-
emperiopolesis (12). Although the mechanisms and functional
significance of this interaction have not been clarified, this
kind of cell interaction seems to be an important step for
stem cells and hematopoietic precursors to differentiate to a
committed lineage, since this multicellular complex has gener-
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systems in vitro (3, 6) . Cell adhesion molecules might be
involved in this cellular interaction, and several cell adhesion
molecules are known to be expressed on stromal cells and
hematopoietic precursors (13-15) . Recently, an antibody to
amurine cell surface glycoprotein, CD44, alsoknown as Pgp-1,
was found to block the production oflymphoid and myeloid
cells when added to some types ofLTBMC (16), suggesting
that this molecule plays an important role for inducing he-
matopoiesis . It is not clear, however, how the antibody exerts
its inhibitory activity on the cell interaction, because Pgp-1
glycoprotein is expressed on both lymphoid/myeloid precursors
and stromal cells (16) . Heparan sulfate, a component ofECM
proteoglycans is expressed on bonemarrow stromal cells (3) ;
this molecule has been suggested to bind soluble factors, such
as 11,3 and granulocyte/macrophage colony-stimulating factor
(GM-CSF) (9, 10), providing at least one function ofECM
molecules in hematopoiesis .
Stromal cells have been shown to produce a number of
cytokines, including macrophage CSF (M-CSF), GM-CSF,
11,6, and IIT7 (17-19) . These factors support the growth of
factor-dependent cell lines without stromal cells in vitro. How-
ever, in in vivo conditions, even ifthese factors are produced,
they are likely to be rapidly removed and/or diluted out by
blood and/or lymph circulation, Thus, short-range interac-
tions (cell contact) between stromal cells and hematopoietic
precursorsmay be necessary for the specific regulation ofhe-
matopoiesis to occur. In the present study, we demonstrate
that lymphoid tumor cell lines can make multicellular com-
plexes with stromal cells, and use this model to analyze the
characteristics of this cell complex formation. By the use of
polyclonal antisera raised against these stromal cells and ab-
sorbed to monospecificity, we identified a large cell surface
molecule consisting of 107-kD glycoprotein subunits as a medi-
ator of such an adhesive event. The possible relationship and/or
identity of this molecule with known stromal/endothelial
adhesion molecule is discussed .
Materials and Methods
CellLines.
￿
The cloned thymic stromal cell lines (BATE-2, BATE-
5, BATE-10, and BATE-12) were established from the cultures of
day 14 fetal thymus fragments ofC57BL/Ka mouse (S. Heimfeld,
manuscript in preparation) . The stromal cell line TSt-thymo was
established from the thymus ofpreleukemic B10.thy-1 .1 mouse ir-
radiated with split doses of X-ray (Watanabe et al., manuscript in
preparation) . The stromal cell line LDF-1 was established from
mesenteric lymph nodes (B. Holzmann, unpublished results) . Bone
marrow stromal cell lines AC-6 (4) and ST2 (5) were established
from LTBMC . These stromal cell lines were established by using
Whitlock-Witte-type culture conditions (2) and cloned by limiting
dilution . Fibroblast lines (NIH-3T3, LTK- , and Cos-7) and mono-
cyte/macrophage lineage lines 0774 .1 and RAW264.7) were ob-
tained from theAmerican Type Culture Collection (Rockville, MD) .
T cell lines (TK 1, TK5, VL3, RPLl, AKR179, 5C2, 16C1, and
C6VL.B) and pre-B cell lines (70Z/3, DW8, SCID7 and DW34)
were also used (5, 20) . Cell lines were maintained in tissue culture
usingRPMI 1640 (Irvine Scientific, Santa Ana, CA) with5% FCS.
Measurement ofCell Complex Formation.
￿
For measuring the for-
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mation of cell complexes between lymphocytes and stromal cells,
10° stromal cells in 100 p,l ofRPMI 1640 containing 5% FCS (5%
FCS-RPMI) were precultured overnight in a microtiter plate (3596 ;
Costar, Cambridge, MA) . After washing with warm RPMI 1640,
the wells were overlaid with 100,ul of2% FCS-RPMI containing
3 x 105 indicator lymphocytes, which were radiolabeled with
Na211Cr04 ("Cr, New England Nuclear, Boston, MA) as de-
scribed (21) . Cells were cultured for 0.5-8 h at 37°C in 5% CO Z
in air. At the end of incubation time, each well was flushed with
200 wl ofwarm RPMI 1640 with a multichannel pipet, and flicked
down vigorously to remove the washing medium . This procedure
was repeated several times and the wells were microscopically checked
for the absence of lymphocyte on the stromal cells or plastic sur-
face . Cells remaining in the wells were then lysed by adding 200
,ul of lysing buffer consisting of1% Triton X-100 in 0 .1M NaOH
solution, and the radioactivity of "Cr was counted in a gamma
counter. Spontaneous release of "Cr from the labeled lymphocytes
(within the range of 5 .0-10% of total input cpm) was counted
and subtracted from the counts in all the assay cultures. Triplicate
cultures were set up for each experimental group and the arith-
metic means plus or minus standard errors were calculated .
When the effects of antisera on thecell complex formation were
tested, the monolayer of stromal cells was pretreated with 100 pl
ofappropriate dilutions ofantiserum for 30 min at room tempera-
ture before the addition of indicator lymphocytes . In the experi-
ments to investigate the time course of inhibition, antiserum was
added to the stromal cell monolayer at the same time or various
times after the addition of indicator lymphocytes.
Production ofAntiserum .
￿
For raising antiserum against BATE-2
cells, Fisher rats were immunized subcutaneously with BATE-2
stromal cells together withCFA (Difco Laboratories, Detroit, MI),
and then boosted four times with intact BATE-2 cells intraperi-
toneally every 2wk . Serum samples were collected individually and
checked for the reactivity against BATE-2 cells by FRCS (a regis-
tered trademark of Becton Dickinson & Co.) analysis . The final
immunization was performed by injecting BATE-2 cells with IFA,
and serum was collected 3 wk later. The serum was heat inacti-
vated and extensively absorbed with RPM cells, normal thymo-
cytes, and erythrocytes before use.
For the production ofa monospecific antiserum against cell sur-
face 107-kD molecules, TSt-thymo stromal cells (-109 ) were lysed
with 5 ml oflysing buffer consisting of1.0% Triton X-100, 0.15 M
NaCl, 2mM PMSF (Sigma Chemical Co ., St . Louis, MO), and
10 U/ml of aprotinin (Sigma Chemical Co.) in 10 mM Tris-HCI
buffer (pH 8.0) for 1 h on ice. The lysate was spun down at 15,000 g
for 15 min, and mixed 1:1 with4%SDS sample buffer in the pres-
ence of 2-ME (2%) . One-fourth of the extract was loaded onto
a 2-mm-thick SDS-polyacrylamide gel, and the gel was run for 6 h
at 40 mA . The gel was stained with 0.01% Coomassie brilliant
blue and fixed in 2% glutaraldehyde solution for 1 h . After de-
staining overnight, the gel band corresponding to 107kD was ex-
cised and homogenized with CFA . The mixture was then injected
subcutaneously into Syrian hamsters . Subsequently, they were in-
jected intraperitoneally three times with the excised band without
adjuvant every 2 wk . The serum was collected 2 wk after the final
boost and heat inactivated before use .
Radioiodination ofStromal Cells and Extraction .
￿
Monolayer cul-
tures of stromalcells in five 10-cm tissue culture dishes were scraped
with rubber policeman, washed three times with HBSS (Irvine
Scientific), and then radiolabeled with 1 mCi ofNa"5I (New En-
gland Nuclear) by using the glucose oxidase-coupled lactoperoxi-
dase method as described by Pink andZiegler (22) . Cells were then
lysed with 50mM Tris-HCI buffer (pH 7.4) containing 1.0% TritonX-100, 0.15 M NaCl, 2mM PMSF, and 10 U/ml of aprotinin for
1 h at 4°C. The lysate was centrifuged at 15,000g for 15 min and
precleared with an equal volume of Pansorbin cells (Calbiochem-
Behring Corp ., San Diego, CA) and subjected to immunoprecipi-
tation .
Immunoprecipitation andSDS-PAGE Analysis.
￿
Immunoprecipi-
tation ofradioiodinated cell surface molecules with protein A-cou-
pled Sepharose CIAB beads (Sigma Chemical Co .) was performed
as described (20) . Briefly, protein A-Sepharose beads (10 P .1) were
incubated with sufficient amount of rabbit anti-rat or anti-ham-
ster IgG antiserum (Pel-Freeze Biologicals, Rogers, AR) for 2 h
at room temperature . After washing the beads with PBS, immune
rat or hamster antiserum was added to the beads and incubated
for 2 h at room temperature, and the beads were blocked with 1%
BSA in PBS for 1 h . The beads were then incubated with '25 I-
labeled precleared lysate (10' cpm) for 5-6 h at 4°C, and exten-
sively washed with 1.0% Triton X-100 in 10mM Tris-HCI buffer,
pH 8.0 . Samples for SDS-PAGE were prepared by boiling 2 min
in the presence of2% SDS with (reducing conditions) or without
(nonreducing conditions) 1% 2-ME, and analyzed on 10% poly-
acrylamide gels . Molecular weights of proteins were estimated by
comparison to the molecular weight standards (Bio-Rad Laborato-
ries, Richmond, CA) .
Endo-glycosidase Digestion.
￿
Endo-glycosidase F digestion ofim-
munoprecipitated materials was done as described (23) . After the
immunoprecipitation, proteinAbeads were washed four times with
lysing buffer and suspended in the elution buffer containing 1%
SDS, 1% 2-ME, and 1% NP-40 in 10 mM Tris (pH 6.8) . The
samples were boiled for 2 min, and the supernatant-containing im-
munoprecipitated materials were then digested with varying units
of endo-(3-N-glycosidase F (Endo F; New England Nuclear) for
2 h at 37°C in the reaction buffer consisting of 1% NP-40, 1%
2-ME, and 56 mM EDTA in 0.1 M phosphate buffer (pH 6.1) .
Digested samples were boiled and loaded onto the 10% polyacryl-
amide gel for the analysis in SDS-PAGE .
Results
Adhesion between Stromal Cells and Hematolymphoid Lines
Can Be Measured In Vitm The formation of multicellular
complexes (pseudo-emperipolesis) between various hemato-
lymphoid lines and stromal cell lines was compared in Fig. 1 .
In Fig . 1 a, the formation of complex between lymphoid cell
lines and the thymic stromal cell clone BATE-2 are shown .
Whereas lymphoid lines showed various levels of activities,
T cell lines RPIrl and TK-1 (a cloned cell line from preleu-
kemic thymus of irradiated C57BL/Ka mouse and a sponta-
neous thymic lymphoma ofAKR mouse, respectively) and
a B cell line, DW8 (derived from Whitlock-Witte-type
LTBMC), showed the highest activity of binding to stroma
(with no nonspecific binding to the plastic surface), thus pre-
senting useful indicator cells for measuring the activity of
cell complex formation . VIr3 and 70Z/3 linesbound to wells
with or without stromal cells, while the cell lines (5C2 and
C6VL.B) did not bind to the stromal cells . It is notable that
cell lines of both T and B lineages showed the binding to
thymic stromal cells.
Using RPIJ1 cells, we compared the binding of this line
to various stromal cell lines, fibroblasts, and macrophage lines.
The results are shown in Fig. 1 b . High levels of binding
were observed with thymic stromal cell lines (BATE-2, -5,
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Figure 1 .
￿
Cell complex formation in various combinations oflymphoid
and stromal cell lines. (a) After an overnight preculture of BATE-2 cells
(104 ) in a microplate, 3 x 105 cells of 5'Cr-labeled T and B lymphoid
cell lines (15,000-25,000 cpm) were added to the monolayer of BATE-2
cells (open columns) or to the control wells without BATE-2 cells (closed
columns), and incubated at 37°C for 1 h . The microplate was extensively
washed with warm RPMl 1640, and cells remaining in the wells were
then lysed in 1% Triton X-100 in 0.1MNaOH solution . Bound counts
per minute was calculated and presented as percentages oftotal input counts
per minute oflymphocytes . (b) Stromal cell lines ofvarious origins, fibro-
blasts, and a macrophage cell line (104 ) were precultured in a microplate,
51Cr-labeled RPIA cells (3 x 105, 15,000 cpm) were cocultured for 1 h,
and the radioactivities were counted after the extensive washings .
-10, and -12) as well as with stromal cell lines derived from
bone marrow (AC-6) and mesenteric lymph node (LDF-1),
whereas the binding activities to typical fibroblast lines (NIH-
3T3 and LTK- ), a macrophage line (J-774.1), and a monkey
fibroblast line (Cos-7) were very low .
In Fig . 2, we characterized several functions of cell com-
plex formation using RPLA cells and BATE-2 stromal cells .
The binding was detectable by 0.5 h and reached maximum
level at 4 h after the initiation of assay (Fig. 2 a) . This ac-
tivity is temperature dependent, in that an optimal response
can be seen at 37°C (Fig . 2 b) . We also analyzed whether
this interaction depends on energy metabolism and a func-
tional cytoskeleton . As shown in Fig. 2 c, this cell interac-
tion was markedly inhibited by the addition of sodium azide
plus 2-deoxy-D-glucose, or cytochalasin B, demonstrating the
dependence on both energy and a functional cytoskeleton .
Since it has been shown in many cell adhesion systems that
the presence of divalent cations are required for binding of
cells to extracellular matrices (24) or for homotypic and het-
erotypic cell conjugate formation (25), we next investigatedb
r - 0
a i
C
2000 4000 6000 8000 10000
Bound CPM
cells (3 x 105) were coincubated with stromal cell monolayers in the presence
HBSS with 5% dialyzed FCS, and the cell complex formation activity was determined 1 h later.
whether divalent cations are required for the cell complex
formation in our system . As shown in Fig . 2 d, the absence
of divalent cations resulted in no measurable cell complex
formation. The activity was recovered when physiological
concentrations ofMgt* were added to the culture, while the
presence of Cal* is not necessary for this cell complex for-
mation .
1 :10 1 :20 1 :40 1 :60 1:160 1:320
Dilution of Antiserum
Figure 3.
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Inhibition of cellcomplex formation by rat anti-BATE-2 serum .
104 BATE-2 and Ac-6 stromal cells were precultured overnight in a
microplate, and50,ul ofvarious dilutions ofrat antiserum against BATE-2
stromal cells (after the extensive absorption with lymphoidcells and erythro-
cytes) was added to the stromal cell monolayers. 51Cr-labeled RPM cells
(3 x 105) were added immediately thereafter, and the cell complex for-
mation was determined 1 h after the incubation . Rat anti-BATE-2 serum
was added to BATE-2 monolayers (O) or to Ac-6 monolayers (p) . Normal
rat serumwas added to BATE-2 monolayers (") or to Ac-6 monolayers (/) .
K
Figure 2 . Characterization of cell
complex formation betweenRPM and
BATE-2 cells. (a) Time course of cell
complex formation . 51Cr-labeled RPIA
cells were added to the wells precultured
with BATE-2 cells (open columns) or
to wells without BATE-2 cells (closed
columns), and the cell complex forma-
tion activity was measured on 0.5, 1,
2, 4, and 8 h later. (b) Temperature
dependence. 51Cr-labeled RPIA cells
were cocultured with BATE-2 stromal
cell monolayer for 1 h at 4, 20, or37°C,
and the bound counts per minute was
calculated as the percentages of input
counts per minute. (c) Requirement for
energy metabolism and cytoskeleton
function . Assay cultures ofcomplex for-
mation between RPL1 and BATE-2
were setup in the presence of 10 mM
sodium azide plus 50 mM 2-dideoxy-
D-glucose, 20,uM cytochalasin B, and
medium alone, as a control . 51Cr ac
I--
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tivities remaining in the wells were mea-
sured after 1 h of incubation . (d) Re-
quirement for Mgt* cation . After an
overnight preculture ofBATE-2 stromal
cells, the monolayers were washed three
times with 200 Ftl of Cat' and Mgt+-
free HBSS, and 51Cr-labeled RP1r1
of various concentrations of MgC12 and CaC12 in Cal+ and Mgt+-free
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An Antibody to Thymic Stromal Cells Blocks Adhesive Inter-
action between Lymphocytes and Stromal Cells. Although we
have tested the effect of various mAbs on the cell complex
formation betweenlymphocytes and stromal cells, so far, none
of antibodies (including anti-LFA-1, anti-CD2, anti-Pgp-1,
antiVLA4, and anti-CD3) were able to block the cell inter-
action (data not shown) . From these results, it is considered
that : (a) a new cell surface molecule, undefined so far, may
mediate this kind ofcell interaction; (b) several kinds ofmol-
ecules may be involved in this phenomenon; or (c) multiple
binding sites (epitopes) of a single moleculemaybe involved
in this interaction . Thus, we tried to make polyclonal an-
tiserum against stromal cells that can block lymphocyte-
stromal cell interaction . Fischer rats were hyper-immunized
with BATE-2 thymic stromal cells, and the immune serum
was collected . The serum was heat inactivated and extensively
absorbed with lymphoid cell lines (RPLl, AKR-179, and
70Z/3), normal mouse thymocytes, and peripheral blood
erythrocytes untilthe serum showed no reactivity against lym-
phoid lines by FACS analysis and by SDS-PAGE analysis of
immunoprecipitated materials of radioiodinated lymphoid lines
(data not shown) . As a control, normal serum of Fischer rat
was similarly treated . To test effects of the serum on the cell
complex formation, varying dilutions ofimmune serum and
normal serum were added to the monolayers ofBATE-2 and
AC-6 stromal cells . "Cr-labeled indicator RPL1 cells were
loaded immediately thereafter, and the plate was incubated
for 1 h at 37°C . After extensive washings, residual radioac-
tivity was counted. As shown in Fig . 3, immune rat serum
0
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Controlcantly inhibited cell complex formation at dilutions from
1:10 to 1:80. This antibody also blocked the cell complex
formation between RPL1 and AC-6 stromal cells (shown
with a open square) . These results may indicate that both
thymic and bonemarrow stromal cells express a similar mol-
ecules) that can mediate the cell interaction between lym-
phocytes and stromal cells .
To investigate the time course of inhibition by the anti-
body, immune serum, normal serum, and control medium
were added to the monolayers ofBATE-2 stromal cells at var-
ious times before or after the initiation ofculture . Cell com-
plex formation was measured after 1 h of incubation . As shown
Figure 4 .
￿
Inhibition of cell complex formation by antiserum and ab-
sorption of inhibitory activity by stromal cells. (a) Assay culture of cell
complex formation between BATE-2 and s'Cr-labeled RPIA cells was
added withrat anti-BATE-2 serum (a-BATE-2) or normal rat serum (NKS)
(50 Al of 1:10 dilution), or with medium alone at 0, 15, 30, or 45 min
after the initiation of culture . A group of stromal cell monolayer was
pretreated with antiserum for 30 min at room temperature and washed
once with warm medium before adding s 1Cr-labeled RPLI cells (pretreat-
ment) . All cultures were assayed for RPIA binding 1 h after the incuba-
tion . (b) Rat anti-BATE-2 antiserum was absorbed extensively with BATE-2,
Ac-6, NIH-3T3, or RAW264.7 cell lines . Absorbed, unabsorbed, and
normal rat serum (50 ttl of 1:10 dilution) were added to the assay culture
of BATE-2 and s 1Cr-labeled RPL1 cells at the initiation of culture . Cell
complex formation was determined 1 h later.
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in Fig . 4 a, while the pretreatment of stromal cells with im-
mune rat serum significantly blocked cell complex forma-
tion, continuous presence of antibody exhibited the highest
inhibition . The blocking activity diminishedwhen antiserum
was added at later stages of assay culture. These results sug-
gest that the antibody inhibits only the initial step of lym-
phocyte-stromal cell interaction, i .e ., the binding step of lym-
phocytes to stromal cells . To investigate whether specific
antibody(ies) caused this blocking, we adsorbed theimmune
serum with various types of adherent cells (BATE-2, AC-6,
NIH-3T3 or RAW264.7 cells), and then evaluated for their
blocking effects on cell complex formation . As shown in Fig.
4 b, while nonadsorbed immune rat serum showed significant
blocking, the serum absorbed with BATE-2, AC-6, or NIH-
3T3 cell lines could not inhibit the cell complex formation .
Macrophage line RAW264.7 was not able to absorb the
blocking activity of the serum. These results indicate that
the molecule(s) commonly expressed on BATE-2, AC-6, and
NIH-3T3 lines but not on RAW264.7 line is(are) important
in lymphocyte-stromal cell interaction .
Identification of a 107-kD Glycoprotein as a Molecule Medi-
ating Stromal Cell-Lymphocyte Interaction. Using polyclonal
rat anti-BATE-2 serum,we next tried to characterize the mole-
cule(s) thatmay be involved in these lymphocyte-stromal cell
interactions. Immunoprecipitation of surface radioiodinated
BATE-2 cells was carried out with immune rat serum unab-
sorbed or absorbed with various stromal cell lines ; the samples
were analyzed by SDS-PAGE (Fig. 5) . As shown in Fig . 5
a, immune rat serum immunoprecipitated several bands of
molecules in reducing conditions, which included one major
band of 107 kD, a minor band of 60 kD, and smear bands
of-90 and 130-150W. Under nonreducing conditions, al-
though a weak band of 200 kD can be seen, most of the
radioactivity is located at the top of the gel, indicating that
the precipitated molecule mainly existed as a large molecular
complex on the cell surface. After adsorption either with
BATE-2, AC-6, or NIH-3T3, most of the bands, including
the major band and the smear bands, except the60-kD band,
were absorbed out (Fig. 5 b) . However, a macrophage line
(RAW264.7) could not absorb the major band ofthe 107-kD
molecule, though other bands (except the 60-kD band) dis-
appeared completely. The 60-kD band appears to represent
molecules nonspecifically bound to antibody-coupled Sepharose
beads . As shown in Fig. 5 c, digestion of the 107-kD mole-
cule with endo-glycosidase F reduced its molecular mass to
97 kD, indicating that the 107-kD molecule is a glycoprotein.
We next tried to raise a monospecific antiserum against
isolated 107-kD molecules in order to confirm whether a
similar binding inhibition activity could be observed with
such serum as with the absorbed polyspecific antiserum against
BATE-2 cells. To do this, preparative-scale SDS-PAGE ofmem-
brane extracts of the TSt-thymo cell line (stromal cell line
expressing high levels ofthe 107-kD molecule) was performed,
and the gel band corresponding to 107 kD was excised and
injected into hamsters as described in Materials and Methods.
After several immunizations, the serum was checked for
monospecific reactivity by immunoprecipitation and SDS-
PAGE analysis, and also tested for an effect on cell complex378
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Figure 5 .
￿
SDS-PAGE analysis of immunoprecipitated
materials from stromal cell surface by rat anti-BATE-2
serum . (a) Radioiodinated lysate of BATE-2 cells was im-
munoprecipitated with normal rat serum or with rat anti-
BATE-2 antiserum absorbed only with lymphoid cells, as
shown in Fig . 3, and analyzed under reducing and non-
reducing conditions by SDS-PAGE . Lane 1, anti-BATE-2
serum, reducing ; lane 2, normal serum, reducing; lane
3, anti-BATE-2 serum, nomeducing ; lane 4, normal serum,
nonreducing . (b) Radioiodinated BATE-2 lysate was im-
munoprecipitated with rat anti-BATE-2 antiserum unab-
sorbed or absorbed with various stromal cells, as shown
in Fig. 4 b, and analyzed by SDS-PAGE under reducing
conditions. (c) After the immunoprecipitation ofradioio-
dinated BATE-2 lysate with rat anti-BATE-2 serum,
samples were digested with varying amounts of endo-
glycosidase F at 37°C for 2 h under reducing conditions,
and analyzed by SDS-PAGE .
Figure 6 .
￿
Production of monospecific an-
tiserum against 107-kD molecule and blocking
of cell complex formation by it . (a) Mono-
specific antiserum against the 107-kD mole-
cule was raised in Syrian hamsters as described
in Materials and Methods. Radioiodinated ly-
sate of BATE-2 cells was immunoprecipitated
with this hamster serum without secondary an-
tibody. Conventional immunoprecipitation by
using polyspecific rat anti-BATE-2 serum and
secondary rabbit anti-rat IgG serum was also
done for comparison. SDS-PAGEwas run under
reducing conditions. Lane 1, rat anti-BATE-2
serum, lane 2, normal rat serum, lane3, ham-
ster anti-107-kD serum, lane 4, normal ham-
ster serum . (b) Monospecific hamster anti-107-
kD serum (a-107-k), rat anti-BATE-2 serum,
and control normal sera (50 Al of 1:10 dilution
ofeach serum) were added to the assaycultures
of complex formation between BATE-2 and
s ,Cr-labeled RPLl cells from the beginning
ofculture ; bound RPL 1 cells were assayed 1 h
later.formation . As shown in Fig. 6, this serum immunoprecipi-
tated the 107AD band (Fig. 6 a), and showed comparable
levels of cell complex blocking activity, as did polyspecific
anti-BATE-2 serum (Fig. 6 b) . Taken together, these results
strongly suggest that the 107-kD glycoprotein (gp107) plays
an important role in the mediation of stromal cell-lympho-
cyte interaction.
Discussion
In this paper, we investigated an adhesive interaction be-
tween lymphocytes and stromal cells ofvarious origins. This
cell interaction can generally be observed in LTBMC. We
demonstrated that the interaction was an active process that
required energy metabolism and cytoskeletal function. The
presence ofMgt+ but not Caz+ is necessary for the interac-
tion to occur. We succeeded in raising an antiserum against
the cell surface component of stromal cells that could block
lymphocyte binding to stromal cells . The antiserum im-
munoprecipitates a 107-kD glycoprotein . Although the pre-
cise molecular nature is not yet clear, it appears that this subunit
exists as oligomers on the stromal cell surface.
Adhesive interactions with stromal cells appear to be in-
dispensable for lymphopoiesis as well as myelopoiesis in
LTBMC . Preferential associations between hematopoietic
precursors and stromal cells have been demonstrated in previous
studies (1-8) . These early studies demonstrated that the
precursors first attached to the stromal cell surface andmove
underneath themembrane of stromal cells. Such interactions
were commonly observed during the development ofB lym-
phocyte and myeloid cells (2, 3) in LTBMC as well as in the
culture of immature thymocytes with thymic stromal cells
(12) . This kind of cellular interaction may be important in
vivo in that commitment ofthe multipotential stem cells to
a particular lineage appears to be induced through these cell-
to-cell interactions . In ontogeny, hematopoiesis occurs in par-
ticular tissues and organs, such as embryonic yolk sack and
fetal liver, or bone marrow and other hematopoietic organs
in the adult .
Soluble factors (cytokines) also appear to play essential roles
for induction and maintenance of hematopoiesis (26) . Al-
though most of the soluble factors (such as G-CSF, M-CSF,
and IL7) support only restricted lineages of hematopoietic
cells, some of the factors are shown to exert a variety offunc-
tions. It is well known that IL-3 is a multi-CSF (27), and
IL6 can exert heterogeneous functions both in vivo and in
vitro (28, 29) . Therefore, contacts between precursors- and
the cells that produce multifunctional factors allow these factors
to function with specific progenitors .
Cell-to-cell adhesion is mediated by a variety of molecules
that possess unique molecular characteristics. Cell adhesion
molecules are grouped into three large families of molecules
known as the integrin family, the immunoglobulin super-
gene family, and the selectin family (30-32) . The integrin
molecules consist of two subunits, a and (3, which are non-
covalently associated. Based on the structure of# subunit,
this family is divided into three subfamilies ((31, /32, and 03)
(33) . Among these subfamilies, the02 subfamily defines LFA1
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molecules, which are involved in lymphoid interactions (34) .
Treatment ofRPIA cells with an anti-LFA1 mAb (17/4.3)
or continuous presence of the antibody in the culture did
not affect the ability ofRPL1 cells to form the cell complex
in our system (data not shown) .
The immunoglobulin supergene family also defines mole-
cules that are involved in cell adhesion . Among these, inter-
cellular adhesion molecule 1 (ICAM-1) and neural cell adhe-
sion molecule (N-CAM) may be involved in hematopoiesis
(35, 36) . The ICAM-1 molecule is a highly glycosylated cell
surface protein of 85 kD and it is a ligand of LFA-1 (21) .
In humans, ICAM-1 is expressed on endothelial cells, fibro-
blasts, and lymphoid cells (37) . However, analyses by amAb
against murine ICAM-1 molecule (38) and cDNA cloning
of this molecule (39) indicated that ICAM-1 is mainly ex-
pressed on macrophages and myeloid cells as well as activated
lymphocytes, but not on stromal cells in the mouse. This
suggests that theICAM-1-LFA-1 pathwaymay not function
as a critical step in the interaction between hematolymphoid
precursors and stromal cells . Although N-CAM is mainly
expressed on cells of the nervous system (36), this molecule
is found in a variety of nonnervous tissues and cells, including
stromal cells (13) and a subset ofearly thymocytes (40) . The
stromal cells used in this study (BATE-2, BATE-10, AC-6,
and ST2) also express this molecule. However, themAb against
murine N-CAM (H-28) (40) could not inhibit cell complex
formation in our system (not shown) .
There is another family ofcell adhesion molecules, termed
selectin (32) or LEC-CAM (41), to which lymphocyte homing
receptor (MEL14) (42), endothelial leukocyte adhesion mol-
ecule 1(ELAM-1) (43), and granule membrane protein GMPR
140 (32) belong. This family does not seem to be important
in the cell interaction between stromal cells and lymphocytes,
since cell adhesion with this family of molecules does not
require active cell metabolism and depends on extracellular
Ca2+ (32) . SDS-PAGE analysis by using mAbs against Pgp-1
(IM7.8.1) (44) and heat-stable antigen (M1/69) (45) revealed
that gpl07 found in this study does not correspond to either
of these molecules (data not shown) .
The most likely candidate of an adhesion molecule that
corresponds to our gp107 species is VCAM-1/INCAM-110
(46-49) . VCAM-1/INCAM-110 is a counterligand forhuman
VLA-4 (a4a1) molecule (46-48) . Elsewhere, we demonstrate
that an anti-murine a4 inhibits a401-expressing hematolym-
phoid cell lines from adhering to LTBMC stroma (Miyake,
K ., I . L . Weissman, J . S. Greenberger, and P.W Kincade,
manuscript submitted for publication) . A proposed receptor
for this a4a1 species on the stromal cells is also -100 kD,
which can be detected by mAbs M/K-1 andM/K-2 (Miyake
et al ., manuscript submitted for publication) . Crossimmu-
noprecipitation experiments demonstrated that the identical
cell surface molecule was immunoprecipitated from both
thymic and bonemarrow stromal cells with these mAbs and
with our antiserum (unpublished results) . Thus, at first sight,
the most likely explanation for our gpl07 is that it is related
to or is identical to the murineVCAM-1/INCAM-110. How-
ever, a few discrepancies prevent that conclusion: we could
not induce or upregulate the gp107 with cytokines/substancesknown to induce VCAM-1 (TNF, IL1 and endotoxin), and
experiments with anti-murine a4 antibodies R1-2 (20) and
PS/2 (Miyake et al., manuscript submitted for publication)
did not inhibit RPL1 binding to BATE-2 cells. Moreover,
some T cell lines that lack VLA-4 possess the ability to form
cell complexeswith thymic stromalcells(unpublished results).
Nevertheless, direct identification will requirethe use of an-
tibodies known to detect murine VCAM-1/INCAM-110.
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